Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1775 of 3284 entries
View as:

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01588548 Org: User:
Start: 07/31/12 End: 07/31/14 Due: 07/31/15

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Phase: N/A Priority: Normal
NCT ID: NCT00750802 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118

Phase: N/A Priority: Normal
NCT ID: NCT01348724 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00986219 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

The Use of International GerdQ Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT01489735 Org: User:
Start: 02/29/12 End: 06/30/12 Due: 06/30/13

Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study

Phase: N/A Priority: Normal
NCT ID: NCT01715155 Org: User:
Start: 12/31/12 End: 06/30/13 Due: 06/30/14

Generalized Anxiety Disorder Adjunct Study

Phase: N/A Priority: Normal
NCT ID: NCT00534599 Org: User:
Start: 08/31/07 End: 09/30/08 Due: 09/30/09

Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT04560452 Org: User:
Start: 03/15/21 End: 09/30/25 Due: 09/30/26

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006049 Org: User:
Start: 05/31/00 End: - Due: -

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Phase: N/A Priority: Normal
NCT ID: NCT01443845 Org: User:
Start: 09/30/11 End: 01/31/16 Due: 01/31/17

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Phase: N/A Priority: Normal
NCT ID: NCT04723394 Org: User:
Start: 01/28/21 End: 10/19/22 Due: 10/19/23

Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04052113 Org: User:
Start: 10/25/19 End: 03/23/20 Due: 03/23/21

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04727528 Org: User:
Start: 03/22/21 End: 09/14/22 Due: 09/14/23

A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

Phase: N/A Priority: Normal
NCT ID: NCT00532922 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

Phase: N/A Priority: Normal
NCT ID: NCT01217905 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart

Phase: N/A Priority: Normal
NCT ID: NCT04256629 Org: User:
Start: 03/03/20 End: 08/21/20 Due: 08/21/21

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06357520 Org: User:
Start: 04/16/24 End: 06/17/24 Due: 06/17/25

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02238483 Org: User:
Start: 10/28/14 End: 04/04/16 Due: 04/04/17

A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years

Phase: N/A Priority: Normal
NCT ID: NCT02269475 Org: User:
Start: 10/31/14 End: 04/30/15 Due: 04/30/16

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT02821416 Org: User:
Start: 10/11/16 End: 10/22/19 Due: 10/22/20

Dapagliflozin Patient Satisfaction Survey

Phase: N/A Priority: Normal
NCT ID: NCT02805283 Org: User:
Start: 06/22/16 End: 10/29/18 Due: 10/29/19

Dose Response Study in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00261417 Org: User:
Start: 05/31/04 End: 10/31/05 Due: 10/31/06

Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04774380 Org: User:
Start: 11/11/21 End: 01/02/25 Due: 01/02/26

PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00099580 Org: User:
Start: 03/31/05 End: 09/30/06 Due: 09/30/07

A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Phase: N/A Priority: Normal
NCT ID: NCT01031836 Org: User:
Start: 11/25/09 End: 07/11/16 Due: 07/11/17